Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001012975-18-000201

10% owner acquired 337,452 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novartis Bioventures Ltd 10% owner 2018-02-13 Other acquisition +269,527 2,804,088 I: show line 1 in the form
Novartis Bioventures Ltd 10% owner 2018-02-15 Other acquisition +67,925 2,872,013 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novartis Bioventures Ltd 10% owner 2018-02-13 Other disposition · Series B Convertible Preferred Stock −344.94 1,724.69 I: show line 3 in the form
Loading xslF345X03/edgar.xml…